News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 19, 2024

Identifying Risk to Enable Early Detection of Type 1 Diabetes

An expert reviews risk factors for type 1 diabetes including autoimmune disease and family history, along with the role of autoimmune antibody screening to enable early disease detection, though access to these specialized tests can be limited.

Episodes in this series

Video 1 - "Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2"

EP. 1 Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2

Video 2 - "Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3"

EP. 2 Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3

Video 3 - "Identifying Risk to Enable Early Detection of Type 1 Diabetes "

EP. 3 Identifying Risk to Enable Early Detection of Type 1 Diabetes

Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"

EP. 4 Challenges in Autoantibody Screening for Type 1 Diabetes

Video 5 - "Strategies for Preventing Progression of Early-Stage Type 1 Diabetes"

EP. 5 Strategies for Preventing Progression of Early-Stage Type 1 Diabetes

Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"

EP. 6 Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus

Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"

EP. 7 Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Zobair M. Younassi, MD

Fibrosis-Focused End Points Could Reshape MASH Trial Design: Zobair M. Younossi, MD

ByBrooke McCormick,Zobair M. Younossi, MD,Laura Joszt, MA

August 11th 2026

Christian Roth, MD

Setmelanotide Cuts BMI 16.5% in Hypothalamic Obesity Trial: Christian Roth, MD

ByGiuliana Grossi,Christian Roth, MD

August 11th 2026

Eva R. Parker, MD | Image Credit: Vanderbilt University Medical Center

Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD

ByBrooke McCormick,Eva R. Parker, MD

August 11th 2026

Experts featured in this series.

Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation

ByKavita Nair, PhD,Anton Porsteinsson , MD,Alireza Atri, MD, PhD

Published: August 10th 2026 | Updated: August 10th 2026

Experts featured in this series.

Choosing Between Approved Therapies: Differentiation, Sequencing, and Black Box Warning Navigation in Alzheimer's Disease Agitation

ByKavita Nair, PhD,Anton Porsteinsson , MD,Alireza Atri, MD, PhD

Published: August 10th 2026 | Updated: August 10th 2026

Trending on AJMC

Trump Childhood Vaccine Order: What It Means for Parents and Payers

FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition

Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL

Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD

Obesity Alters Psoriasis Severity and Biologic Response, Review Finds